Diagnostic Reagent Manufacturing and Supply
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the manufacture and supply of a liquid immunohematology reagent known as CONTROL, COOMBS TEST, specifically designed for blood compatibility testing in clinical settings. The product must meet stringent clinical and technical specifications to ensure accuracy and reliability in diagnostic applications, supporting critical transfusion and hematological procedures. The reagent is intended for use in blood bank and laboratory environments where precise detection of antibodies is essential for patient safety. This is a subcontract under the Department of Defense’s Medical Supply Chain, with the place of performance designated as San Antonio, Texas, 78226. The solicitation was posted on July 12, 2026, and responses are due by July 20, 2026, with the NAICS code 325414 indicating classification within the pharmaceutical and biological product manufacturing sector. The contract is part of a broader effort to ensure reliable access to essential diagnostic reagents for military and defense medical operations, requiring compliance with quality, scalability, and supply continuity standards aligned with federal healthcare and defense requirements.
General Info
Agency
NAICS
Place of Performance
SAN ANTONIO, TX, 78226, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
